Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.56B | 3.66B | 3.81B | 3.97B | 3.98B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.56B | 3.66B | 3.81B | 3.97B | 3.98B |
| Cost of Revenue | 1.80B | 1.82B | 1.79B | 1.78B | 1.73B |
| Gross Profit | 1.76B | 1.84B | 2.01B | 2.19B | 2.25B |
| SG&A Expenses | 1.20B | 1.21B | 1.21B | 1.18B | 1.17B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -28.41M | -46.35M | -50.40M | -58.98M | -57.45M |
| Total Operating Expenses | 3.22B | 3.25B | 3.23B | 3.20B | 3.15B |
| Operating Income | 343.43M | 414.49M | 582.86M | 770.61M | 831.23M |
| Income Before Tax | 381.88M | 463.62M | 627.72M | 837.65M | 886.33M |
| Income Tax Expenses | 82.67M | 96.54M | 141.93M | 192.59M | 208.62M |
| Earnings from Continuing Operations | 299.21 | 367.07 | 485.79 | 645.06 | 677.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.36M | 4.34M | 4.37M | 5.18M | 4.04M |
| Net Income | 303.57M | 371.41M | 490.16M | 650.24M | 681.75M |
| EBIT | 343.43M | 414.49M | 582.86M | 770.61M | 831.23M |
| EBITDA | 556.26M | 630.04M | 797.26M | 980.85M | 1.04B |
| EPS Basic | 0.36 | 0.45 | 0.59 | 0.78 | 0.82 |
| Normalized Basic EPS | 0.28 | 0.34 | 0.47 | 0.63 | 0.66 |
| EPS Diluted | 0.36 | 0.45 | 0.59 | 0.78 | 0.82 |
| Normalized Diluted EPS | 0.28 | 0.34 | 0.47 | 0.63 | 0.66 |
| Average Basic Shares Outstanding | 3.33B | 3.33B | 3.33B | 3.33B | 3.33B |
| Average Diluted Shares Outstanding | 3.33B | 3.33B | 3.33B | 3.33B | 3.33B |
| Dividend Per Share | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| Payout Ratio | 22.97% | 20.54% | 15.56% | 11.73% | 11.19% |